KEY FINDINGS The Europe anti-rheumatics market is predicted to reach a CAGR of 2.10% over the forecast period of 2020-2028. A huge patient base of rheumatoid arthritis, owing to a large geriatric population, is one of the crucial factors favoring the market growth in the region.
MARKET INSIGHTS The Europe anti-rheumatics market is researched further by segmenting the region into countries such as France, Russia, the UK, Poland, Germany, Belgium, Italy, and the rest of Europe that comprises of Greece, Austria, Netherland, Switzerland, Spain, Ireland, among others. In Russia, the prevalence of RA is estimated at 0.61% and has remained stable over the years. RA has been associated with many humanistic outcomes in spite of its low prevalence. Rheumatic disease is the second most common pathology after cardiovascular disorders, with 10% of the population being affected by RD. The most common RDs are osteoarthritis, rheumatoid arthritis, gout, and low back pain. The major factors responsible for the rising prevalence of RDs are hypertension, obesity, diabetes mellitus, and others. In countries like Belgium, the RA deaths accounted for 0.07% of the total deaths. Currently, around 80,000 to 100,000 people have this medical condition in Belgium. Since there is no known cure for RA, physicians focus on suppressing the disease. Therapies have improved in recent years, and intensive treatment in the early stages of RA can prevent joint damage and improve quality of life. The rapid improvement in therapy is driving the market. In Poland, the most widely used DMARDs is methotrexate, which, in accordance with EULAR recommendations, is administered in RA treatment.Moreover, the program for the treatment of GPA and MPA was introduced, thereby promoting the market growth.
The prevalence of RA, together with the increasing healthcare facilities, are propelling the market growth in the rest of Europe.
COMPETITIVE INSIGHTS F. Hoffmann-La Roche Ltd, Abbott Laboratories, Novartis International AG, UCB, Becton, Dickinson, and Company, etc. are some of the renowned companies functioning in the market.
Companies mentioned 1. ABBOTT LABORATORIES 2. ABBVIE INC 3. AMGEN INC 4. BECTON, DICKINSON & COMPANY (BD) 5. BIO-RAD LABORATORIES INC 6. BRISTOL-MYERS SQUIBB COMPANY 7. ELI LILLY & COMPANY 8. LUPIN LIMITED 9. F. HOFFMANN-LA ROCHE 10. JOHNSON & JOHNSON 11. MERCK & CO INC 12. NOVARTIS AG 13. PERKINELMER 14. PFIZER INC 15. UCB
Our reports have been used by over 10K customers, including:
Melanoma - Epidemiology Forecast to 2029
Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of the skin (World Health Organization, 2017).Melanocytes are embryological derivatives of neural crest tissue, and...
573 pages •
By Global Industry Analysts
• Apr 2021
- Looking Beyond Today’s Challenges to Tomorrow’s Healthcare Needs. Genetic Testing to Reach $18.9 Billion as the Burden of Non-Communicable Diseases Grows Bigger
- The global market for Genetic Testing is forecast to reach US$18.9 billion by the year 2027, trailing a post COVID-19 CAGR of 8.6% over the...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The global queue management system(QMS) market size to grow from USD 0.5 billion in 2020 to USD 0.6 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period. Factors such as the increasing need to manage customer traffic and customer movement to boost productivity and the rising need to improve staff efficiency...
Urinalysis market is expected to exibhit a growth of 7.5% CAGR during the forecast period. The higher burden of chronic diseases and rising adaptation of point of care testing is expected to be the major contributing factors for the market growth. Urinary tract infection refers to the infection in any part of the urinary system. According...
208 pages •
By Global Industry Analysts
• Apr 2021
- Global HPLC Systems and Accessories Market to Reach $4.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for HPLC Systems and Accessories estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$4.9 Billion by 2027, growing at a CAGR of 3.2% over the analysis...
The global post-COVID-19 CCM market size is forecasted to grow from USD 1.3 billion in 2021 to USD 2.2 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period. The major growth drivers for the market include increasing adoption of CCM solutions and services in various verticals such as IT and telecom, retail...
175 pages •
By The Business Research Company
• May 2021
Major players in the payer services market are United Health Group, Anthem, Concentrix Corporation, United Healthcare, Anthem Inc., Aetna, Inc., CIGNA Corp., HealthPartners, Blue Cross Blue Shield of Massachusetts, and Group Health Cooperative. The global payer services market is expected to grow from $93.905 billion in 2020 to $101.764...
The global healthcare IT market exhibited strong growth during 2015-2020. The term healthcare refers to the diagnosis, treatment and prevention of diseases or illnesses, and other physical and mental impairments. The healthcare industry along with information technology (IT) functions to manage, regulate, and mechanize...
The Middle East and Africa Artificial Intelligence (AI) in healthcare market is expected to reach US$ 5,713.28 million by 2027 from US$ 222.03 million in 2019; it is estimated to grow at a CAGR of 48.8% from 2020 to 2027. The growth of the market is attributed to the driving factors such as rising application of artificial intelligence (AI)...
Medical Technology Density
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.